, Leadership, Response Biomedical

Meet the leaders in our industry

Response Biomedical focuses on providing diagnostic tools that aid in the diagnosis of life-threatening diseases and we as a team are passionate about the patient’s experience.

Our focus is on providing lab quality results in minutes and our RAMP technology delivers a total solution for making better, faster decisions.

Dr. Barbara Kinnaird, Ph.D.

Chief Executive Officer

“Our team at Response is passionate about improving the lives of patients and their families around the world through providing accurate diagnostic test results.  We are a diverse team of people originating from 29 countries which is a key differentiator in driving our global growth strategy.”

Dr. Barbara Kinnaird has served as Chief Executive Officer since May, 2015. Prior to taking on this role, Dr. Kinnaird had Executive Management responsibility for Product Development, Quality, Regulatory, Manufacturing and Sales after joining the Company in 2004. Through Dr. Kinnaird’s leadership, the Company has expanded from Cardiac Point of Care testing into a global Acute Care Diagnostics leader, transforming diagnostic testing worldwide, with the central focus on better patient diagnosis, improving patient outcomes and supporting healthcare reform. Dr. Kinnaird demonstrates a passion for growing local businesses and building a leadership culture and she is the Chairman of the Board of ACETECH, a local CEO member-based organization run by CEOs for CEOs. The organization is designed to help grow and scale tech businesses and stimulate the economy through job creation and global expansion.

Dr. Kinnaird led the Company through several financings to support the development and commercialization of transformative technologies that impact patients globally. Dr. Kinnaird’s priorities are on building elite teams that specialize in managing organizational changes to improve Company’s processes, reduce costs and accelerate business performance. Dr. Kinnaird’s team has obtained Health Canada certification for 12 products and maintains key regulatory approvals to support sales in several global jurisdictions such as Health Canada approvals, FDA clearance (US), CE Mark (EU), MHLW (Japan), NMPA (China). The Company also has a world-class R&D and manufacturing facility located in Vancouver, Canada which is part of the medical device single audit program.

Dr. Kinnaird has over 25 years of research and business experience in the fields of Acute Care Diagnostics and Point of Care (POC) testing. Dr. Kinnaird holds a Ph.D. in Microbiology and Immunology from the University of British Columbia. She conducted her post-doctoral research at the Michael Smith Laboratories in genomics and gene expression profiling, in collaboration with the B.C. Genome Sciences Centre and consulted for the Proteomics division of Incyte Genomics Inc.

Anastasios Tsonis, CPA, CA

Vice President, Finance and Administration

Anastasios Tsonis joined the Company in 2011 and brings extensive experience in global finance, accounting, and assurance. Mr. Tsonis is responsible for budgeting and forecasting, maintaining effective financial controls, completing the financial reporting requirements, managing treasury requirements, ensuring corporate compliance, and overseeing the day-to-day accounting and finance functions. Mr. Tsonis leads the development and execution of the company’s global long-term financial strategy along with driving profitable growth, maintaining effective financial controls and ensuring corporate compliance. Mr. Tsonis brings a high level of expertise to financial analysis required to support strategic decision-making and business strategy formulation which has been a critical asset to the company’s overall success. Before joining Response, he worked in public accounting with Ernst & Young.

Angela Carter BSC (Hons)

Vice President, Global Channel Strategy
“We’re working strategically with our partners to help them be leaders in their markets.” Angela Carter joined the company in 2005 and is responsible for global channel strategy and Customer Support. Ms. Carter has played a key role in working strategically with Response Biomedical’s distribution partners to increase sales internationally. Her in-depth clinical and technical knowledge is a key driver in continued sales growth at Response. Ms. Carter has extensive expertise in in vitro diagnostics primarily in the areas of new Product Development, Clinical and Technical Support and Sales and Marketing. Her unique experience across multiple laboratory settings provides an exceptional perspective for driving and supporting technical sales and a keen understanding of the diagnostic landscape for multiple disease states.  At Response Ms. Carter has held several management positions including Quality Control and Analytical Development Manager and Manager of Worldwide Product Support.   Ms. Carter holds an Honours degree in Biochemistry and has worked in research labs at Simon Fraser University, the University of British Columbia and the University of Toronto in the fields of molecular biology, proteomics and microarrays. Previous to Response, Ms. Carter gained industry experience at Kinetek Biotechnology Ltd. where she focused on innovative diagnostics design for a novel cancer marker and at ID Biomedical where she worked in assay development for drug-resistant bacteria.